Anaphylactoid reactions to oral, topical, and parenteral corticosteroids have been reported.'-' This may present serious problems in management should steroid treatment be required. We describe a patient who showed an anaphylactoid reaction to several different corticosteroid preparations and was successfully desensitised to hydrocortisone.
Anaphylactoid reactions to oral, topical, and parenteral corticosteroids have been reported.'-' This may present serious problems in management should steroid treatment be required. We describe a patient who showed an anaphylactoid reaction to several different corticosteroid preparations and was successfully desensitised to hydrocortisone.
Case report A 31 year old woman with a history of urticaria and chest tightness precipitated by salicylate ingestion was admitted in 1972 with an acute attack of asthma (FEV, 1.05 1). On discharge she was having prophylactic treatment that included 7.5 mg prednisolone daily, (FEV, 1.65 1). Six months later she developed an urticarial eruption over the upper face; she had ingested no salicylates. Beclomethasone dipropionate by inhalation was introduced and the oral prednisolone reduced to 2.5 mg daily; the rash subsided. The patient remained well with 2.5 mg prednisolone daily for six years (FEV, 1.50-1.90 1), but after worsening of her asthma (FEV, 0.75 1) the dose of oral prednisolone was increased to 7.5 mg daily and there was a recurrence of urticaria over the face and trunk associated with truncal and limb purpura. Investigations including platelet count, Hess test, clotting factor assays, and tests for platelet adhesion and aggregation with collagen and ADP showed no abnormality. The prednisolone was withdrawn and tetracosactrin depot 1 mg intramuscularly twice weekly was introduced. Initially basal plasma cortisol concentrations were low (<50 nmol/l) and rose little in response to tetracosactrin. About six weeks after the introduction of tetracosactrin depot, although the morning cortisol concentration remained low, the response had improved-a cortisol concentration of 1175 nmol/I being achieved. Initially the urticaria and purpura subsided, but after three months it was noted that the rash recurred within 24 hours of administration of tetracosactrin, subsiding again over the following 48 hours. During two weeks while on holiday the patient received no tetracosactrin and remained well and free of rash during this period. Twenty four hours after receiving a further injection of tetracosactrin she developed right iliac fossa pain and an extensive pruritic papular eruption over the face, limbs, and buttocks. Tetracosactrin treatment was withdrawn and, as she would not comply in taking steroid by inhalation, attempts were made to treat her with non-steroidal antiasthmatic drugs. Her condition deteriorated (FEV, 0.80 1) and for the first time she was treated with 200 mg hydrocortisone succinate given intravenously. Within four hours she developed right iliac fossa pain, melaena, and purpura over limbs, buttocks, and trunk, which regressed in 72 hours after treatment with both oral and intravenous chlorpheniramine maleate. A 
Discussion
The patient reported here developed hypersensitivity reactions to several corticosteroid preparations from both systemic administration and skin testing. The intradermal provocation tests showed that the reactions were caused by the steroids themselves rather than by additives, distilled water, or a physical scratch.
Prolonged treatment, even with relatively small doses of synthetic glucocorticoids, may cause adrenal atrophy and consequent impairment of the response to tetracosactrin.
The initial lack of any adverse response to tetracosactrin reflects the poor rise in cortisol at this time. Recurrence 
